NCT05532267View on ClinicalTrials.gov

Bioequivalence Study of Ciprofloxacin in Healthy Adult Subjects Under Fasting Condition

PHASE1CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

November 4, 2020

Primary Completion Date

November 13, 2020

Study Completion Date

November 13, 2020

Conditions
Healthy Subjects
Interventions
DRUG

Ciprofloxacin 750 mg

an immediate release film-coated tablet containing 750 mg Ciprofloxacin

DRUG

Ciproxin 750 mg

an immediate release film-coated tablet containing 750 mg Ciprofloxacin

Trial Locations (1)

11835

Future Research Center (FRC), Cairo

All Listed Sponsors
lead

Future University in Egypt

OTHER

NCT05532267 - Bioequivalence Study of Ciprofloxacin in Healthy Adult Subjects Under Fasting Condition | Biotech Hunter | Biotech Hunter